` SEQUA (Sequana Medical NV) vs DAX Index Comparison - Alpha Spread

SEQUA
vs
D
DAX Index

Over the past 12 months, SEQUA has underperformed DAX Index, delivering a return of +3% compared to the DAX Index's +20% growth.

Stocks Performance
SEQUA vs DAX Index

Loading
SEQUA
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
SEQUA vs DAX Index

Performance Gap Between SEQUA and GDAXI
HIDDEN
Show

Performance By Year
SEQUA vs DAX Index

Loading
SEQUA
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Sequana Medical NV vs Peers

DAX Index
SEQUA
ABT
ISRG
BSX
SYK
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Sequana Medical NV
Glance View

Market Cap
49m EUR
Industry
Health Care

Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 60 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.

SEQUA Intrinsic Value
HIDDEN
Show
Back to Top